TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 66 filers reported holding TCR2 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | +57.1% | 7,678 | +10.7% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 6,937 | +84.5% | 0.00% | – |
| Q3 2022 | $7,000 | -63.2% | 3,759 | -44.1% | 0.00% | – |
| Q2 2022 | $19,000 | -29.6% | 6,727 | -30.6% | 0.00% | – |
| Q1 2022 | $27,000 | -66.7% | 9,696 | -44.4% | 0.00% | -100.0% |
| Q4 2021 | $81,000 | +22.7% | 17,438 | +124.9% | 0.00% | -50.0% |
| Q3 2021 | $66,000 | +50.0% | 7,753 | +188.0% | 0.00% | +100.0% |
| Q2 2021 | $44,000 | -12.0% | 2,692 | +18.7% | 0.00% | 0.0% |
| Q1 2021 | $50,000 | +78.6% | 2,267 | +146.4% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | -92.6% | 920 | -95.0% | 0.00% | -75.0% |
| Q3 2020 | $376,000 | +889.5% | 18,528 | +641.4% | 0.00% | +100.0% |
| Q2 2020 | $38,000 | +153.3% | 2,499 | +27.8% | 0.00% | +100.0% |
| Q1 2020 | $15,000 | -55.9% | 1,955 | -17.5% | 0.00% | -66.7% |
| Q4 2019 | $34,000 | +750.0% | 2,371 | +720.4% | 0.00% | – |
| Q3 2019 | $4,000 | -80.0% | 289 | -79.0% | 0.00% | -100.0% |
| Q2 2019 | $20,000 | +5.3% | 1,375 | +27.2% | 0.00% | 0.0% |
| Q1 2019 | $19,000 | – | 1,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |